Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial.
暂无分享,去创建一个
T. Monath | R. Shope | J. Tian | N. Thomas | P. Bedford | R. Nichols | L. Moore | W. T. Archambault | Ron Marchesani | R. Schrader | D. Furby | Jason Tian